MedTrace Logo

Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia

NCT06380062 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2024-04-25

No results posted yet for this study

Summary

The aim of this study was to investigate plasma concentrations of one-carbon metabolites and phospholipid classes in participants with primary prostate cancer and those with benign hyperplasia. Moreover, the metabolites were studied in relation to tumor grade and age.

Conditions

  • Primary Prostate Urothelial Cancer
  • Benign Prostatic Hyperplasia

Interventions

OTHER

Plasma concentration of choline

The exposure in this observational study is plasma concentrations of choline

Sponsors & Collaborators

  • Universität des Saarlandes

    lead OTHER

Principal Investigators

  • Rima Obeid, PhD · Saarland University Hospital

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-12
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06380062 on ClinicalTrials.gov